Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The closing price of Lexeo Therapeutics Inc (NASDAQ: LXEO) was $4.61 for the day, up 5.25% from the previous closing price of $4.38. In other words, the price has increased by $5.25 from its previous closing price. On the day, 0.79 million shares were traded.
Ratios:
Our analysis of LXEO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.42 and its Current Ratio is at 3.42. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.08.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Robert W. Baird on June 13, 2024, initiated with a Outperform rating and assigned the stock a target price of $28.
On November 28, 2023, Stifel started tracking the stock assigning a Buy rating and target price of $20.Stifel initiated its Buy rating on November 28, 2023, with a $20 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 16 ’25 when Townsend Richard Nolan sold 1,074 shares for $2.77 per share. The transaction valued at 2,979 led to the insider holds 221,173 shares of the business.
Adler Eric sold 585 shares of LXEO for $1,623 on May 16 ’25. The Chief Medical Officer now owns 67,681 shares after completing the transaction at $2.77 per share. On May 16 ’25, another insider, Robertson Jenny, who serves as the Chief Legal Officer of the company, sold 521 shares for $2.77 each. As a result, the insider received 1,445 and left with 63,098 shares of the company.
Stock Price History:
Over the past 52 weeks, LXEO has reached a high of $19.50, while it has fallen to a 52-week low of $1.45. The 50-Day Moving Average of the stock is 49.55%, while the 200-Day Moving Average is calculated to be -23.28%.
Shares Statistics:
A total of 33.19M shares are outstanding, with a floating share count of 25.03M. Insiders hold about 24.61% of the company’s shares, while institutions hold 90.35% stake in the company.
